Am Belvedere 10
Vienna 1100
Austria
43 1 79 777 310
https://www.semperitgroup.com
Settore/i:
Settore:
Impiegati a tempo pieno: 6.282
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Karl Haider | Chairman of the Exec. Board & CEO | N/D | N/D | 1965 |
Dr. Helmut Sorger | CFO & Member of Exec. Board | N/D | N/D | 1978 |
Mr. Gerfried Eder | Chief Industrial Officer & Member of Exec. Board | N/D | N/D | N/D |
Magistrate Clemens Taschée | Head of Group Accounting & Reporting | N/D | N/D | N/D |
Judit Helenyi | Director of Investor Relations | N/D | N/D | N/D |
Ms. Martina Buechele | Head of Group Communications | N/D | N/D | N/D |
Mr. Michael Wolfram | Head of Semperform & Corp. Devel. | N/D | N/D | N/D |
Dr. Berthold Stöger | Head of Global HR | N/D | N/D | N/D |
Mr. Armin Holzner | Head of R&D | N/D | N/D | N/D |
Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through five segments: Sempermed, Semperflex, Sempertrans, Semperform, and Semperseal. The Sempermed segment manufactures surgical gloves in the medical area. The Semperflex segment develops, produces, and sells hydraulic and industrial hoses that are used in the construction and transport industry, as well as in mines and and agricultural machinery. The Sempertrans segment provides conveyor and transport belts for use in mining, steel, cement, civil engineering, and transport industries, as well as in power stations. The Semperform segment offers escalator handrails; ropeway rubber rings; anti-vibration membranes for skis and snowboards; and customized injection moulding and extrusion parts with sealing or damping functions. The Semperseal segment provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. The company was founded in 1824 and is headquartered in Vienna, Austria.
L'ISS Governance QualityScore di Semperit Aktiengesellschaft Holding al 28 settembre 2023 è 10. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 10; diritti degli azionisti: 6; retribuzione: 10.